RaoKBPallakiMTolbertSRHornickTR. Enhanced hypoprothrom-binemia with warfarin due to azithromycin. Ann Pharmacother2004;38(6):982–5.
2.
AdamsP. Drug interactions that matter. (2) Warfarin. Pharmaceutical Journal1998;261:704–8.
3.
HowardPAEllerbeckEFEngelmanKKPattersonKL. The nature and frequency of potential warfarin drug interactions that increase the risk of bleeding in patients with atrial fibrillation. Pharmacoepidemiol Drug Saf2002;11(7):569–76.
4.
FreedmanMDOlatidoyeAG. Clinically significant drug interactions with the oral anticoagulants. Drug Saf1994;10(5):381–94.
5.
RicePJPerryRJAfzalZStockleyIH. Antibacterial prescribing and warfarin: a review. Br Dent J2003;94(8):411–5.
6.
WellsPSHolbrookAMCrowtherNRHirshJ. Interactions of warfarin with drugs and food. Ann Intern Med1994;121(9):676–83.
7.
AmentPWBertolinoJGLiszewskiJL. Clinically significant drug interactions. Am Fam Physician2000;61(6):1745–54.
8.
CroppJSBusseyHI. A review of enzyme induction of warfarin metabolism with recommendations for patient management. Pharmacotherapy1997;17(5):917–28.
9.
DavydovLYermolnikMCuniLJ. Warfarin and amoxicillin/clavulanate drug interaction. Ann Pharmacother2003;37(3):367–70.
10.
ObergKC. Delayed elevation of international normalized ratio with concurrent clarithromycin and warfarin therapy. Pharmacotherapy1998;18(2):386–91.
HortonJDBushwickBM. Warfarin therapy: evolving strategies in anticoagulation. Am Fam Physician1999;59(3):635–46.
13.
AnsellJHirshJPollerLBusseyHJacobsonAHylekE. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest2004;126(3 Suppl):204S–233S.
14.
BiancoTMBusseyHIFarnettLELinnWDRoushMKWongYW. Potential warfarin-ciprofloxacin interaction in patients receiving long-term anticoagulation. Pharmacotherapy1992;12(6):435–9.
15.
HirshJ. Guidelines for antithrombotic therapy. 4th ed.Hamilton: BC Decker Inc.; 2001.
